Pfizer: Gastroesophageal Reflux trials
The registry lists 10 Gastroesophageal Reflux studies with Pfizer as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 2 1Phase 3 8Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsTerminatedNCT02401035Phase 4Results posted
- Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)CompletedNCT00868296Phase 3Results posted
- Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedNCT00365300Phase 3Results posted
- Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERDCompletedNCT00362609Phase 3Results posted
- Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)CompletedNCT00300755Phase 3Results posted
- Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERDCompletedNCT00259012Phase 3Results posted
- Study Evaluating Pantoprazole in Children With GERDCompletedNCT00141817Phase 3Results posted
- Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)TerminatedNCT00730665Phase 2
- Study Evaluating Pantoprazole in Adolescents With GERDCompletedNCT00367614Phase 3
- Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive EsophagitisCompletedNCT00195208Phase 3